Pharmacodynamics of two different propofol formulations;Pharmakodynamik zweier unterschiedlicher propofolformulierungen

Anaesthesist

Volumn 55, Issue 6, 2006, Pages 635-642

  Ihmsen, H ^a,b   Jeleazcov, C ^a   Schuttler J ^a   Schwilden, H ^a   Bremer, F ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cross over study; EEG; Formulation; Pharmacodynamics; Propofol

Indexed keywords

PROPOFOL;

ACOUSTICS; ARTICLE; COMPUTER ANALYSIS; CORNEA REFLEX; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; DRUG INFUSION; ELECTROENCEPHALOGRAM; EYELID REFLEX; HUMAN; NORMAL HUMAN; STIMULUS RESPONSE; VOLUNTEER;

ACOUSTIC STIMULATION; ADULT; ALGORITHMS; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; BLINKING; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; ELECTROENCEPHALOGRAPHY; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MODELS, STATISTICAL; PROPOFOL; REFLEX;

EID: 33746233447     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-006-0987-6     Document Type: Article

References (23)

1. Billard V, Gambus PL, Chamoun N, Stanski DR, Shafer SL (1997) A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect. Clin Pharmacol Ther 61:45-58
2. Calvo R, Telletxea S, Leal N et al. (2004) Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients. Acta Anaesthesiol Scand 48:1038-1048
3. Chernik DA, Gillings D, Laine H et al. (1990) Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol 10:244-251
4. Daunderer M, Schwender D (2001) Messung der Narkosetiefe, Awareness und EEG. Anaesthesist 50:231-241
5. Doenicke AW, Roizen MF, Rau J, O'Connor M, Kugler J, Klotz U, Babl J (1997) Pharmacokinetics and pharmacodynamics of propofol in a new solvent. Anesth Analg 85:1399-1403
6. Dutta S, Ebling WF (1998) Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats. J Pharm Pharmacol 50:37-42
7. Egan TD, Kern SE, Johnson KB, Pace NL (2003) The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroencephalographic and hemodynamic study in a porcine model. Anesth Analg 97:72-79
8. Fechner J, Albrecht S, Ihmsen H, Knoll R, Schwilden H, Schuttler J (1998) Prädiktivität und Präzision einer "target-controlled infusion" (TCI) von Propofol mit dem System "Disoprifusor TCI". Anaesthesist 47:663-668
9. Fechner J, Ihmsen H, Hatterscheid D et al. (2004) Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion. Anesthesiology 101:626-639
10. Forrest FC, Tooley MA, Saunders PR, Prys-Roberts C (1994) Propofol infusion and the suppression of consciousness: the EEG and dose requirements. Br J Anaesth 72:35-41
11. Holford NH, Sheiner LB (1982) Kinetics of pharmacologic response. Pharmacol Ther 16:143-166
12. Ihmsen H, Jeleazcov C, Schuttler J, Schwilden H, Bremer F (2004) Präzision von Target Controlled Infusion (TCI) mit zwei unterschiedlichen Propofolformulierungen. Anaesthesist 53:937-943
13. Jeleazcov C, Bremer F, Schwilden H (2005) Identifikation geeigneter EEG-Parameter für das Narkose-Monitoring durch simultane Analyse von klinischen Endpunkten und Signal-Rausch-Verhältnis. Anaesthesiol Intensivmed 46:561-562
14. Jeleazcov C, Fechner J, Schwilden H (2005) Electroencephalogram monitoring during anesthesia with propofol and alfentanil: the impact of second order spectral analysis. Anesth Analg 100:1365-1369
15. Knibbe CA, Aarts LP, Kuks PF, Voortman HJ, Lie AHL, Bras LJ, Danhof M (2000) Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery. Eur J Clin Pharmacol 56:89-95
16. Marsh B, White M, Morton N, Kenny GN (1991) Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 67:41-48
17. Miller A, Sleigh JW, Barnard J, Steyn-Ross DA (2004) Does bispectral analysis of the electroencephalogram add anything but complexity? Br J Anaesth 92:8-13
18. Plummer GF (1987) Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr 421:171-176
19. Rampil IJ (1998) A primer for EEG signal processing in anesthesia. Anesthesiology 89:980-1001
20. Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, Youngs EJ (1999) The influence of age on propofol pharmacodynamics. Anesthesiology 90:1502-1516
21. Theilen HJ, Adam S, Albrecht MD, Ragaller M (2002) Propofol in a medium- and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg 95:923-929
22. Varvel JR, Donoho DL, Shafer SL (1992) Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 20:63-94
23. Ward DS, Norton JR, Guivarc'h PH, Litman RS, Bailey PL (2002) Pharmacodynamics and pharmacokinetics of propofol in a medium-chain triglyceride emulsion. Anesthesiology 97:1401-1408